between ODI and pulmonary artery systolic pressure.

<p>between ODI and pulmonary artery systolic pressure.</p

Echocardiographic characteristics of patients with and without SDB.

<p>Echocardiographic characteristics of patients with and without SDB.</p

Kaplan-Meier curves for the clinical endpoints including mortality (A), readmission for heart failure (B), recurrent infarction (C) and the combined endpoint of mortality, readmission for heart failure and recurrent infarctions (D).

<p>Kaplan-Meier curves for the clinical endpoints including mortality (A), readmission for heart failure (B), recurrent infarction (C) and the combined endpoint of mortality, readmission for heart failure and recurrent infarctions (D).</p

Markers of inflammation and oxidative stress in patients with and without SDB.

<p>Markers of inflammation and oxidative stress in patients with and without SDB.</p

Baseline Clinical Characteristics according to ODI.

<p>Data are mean ± SD or number (%). Continuous variables were compared using unpaired <i>t</i> test. Categorical variables were compared by the χ² statistic.</p><p>ACE  =  Angiotensin converting enzyme; ARBs  =  Angiotensin II receptor blockers.</p

Unadjusted and Adjusted Cox's proportional Hazards Model for Clinical Endpoints in Patients with SDB.

<p>Models were adjusted for age, gender, BMI and PASP.</p

Receiver-operating characteristic curves for the performance of ODI in the prediction of mortality (A), congestive heart failure (B), recurrent infarction (C) and the combined endpoint of mortality, readmission for heart failure and recurrent infarctions (D).

<p>Receiver-operating characteristic curves for the performance of ODI in the prediction of mortality (A), congestive heart failure (B), recurrent infarction (C) and the combined endpoint of mortality, readmission for heart failure and recurrent infarctions (D).</p